Dominique Goedhals

Dominique Goedhals

Auto-generated profile, based on publicly available information

Dominique Goedhals

University of the Free State

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in mBio
Verified
Journal Article
Open access
PDF file
WNWern Hann Ng
Wern Hann Ng
TTTipih Thomas
Tipih Thomas
Nigel Aminake MakoahNigel Aminake Makoah
Nigel Aminake Makoah
JVJan-G Vermeulen
Jan-G Vermeulen
DGDominique Goedhals
Dominique Goedhals
SMSuresh Mahalingam
Suresh Mahalingam
COVID-19 has plagued the world since it was first identified in December 2019. Previous systematic reviews and meta-analysis were limited by various factors such as the usage of non-peer reviewed data and were also limited by the lack of clinical data on a global scale.

15 December 2021 in Future Virology
Verified
Journal Article
Open access
Nigel Aminake MakoahNigel Aminake Makoah
Nigel Aminake Makoah
TTTipih Thomas
Tipih Thomas
MLMatefo M Litabe
Matefo M Litabe
MBMareza Brink
Mareza Brink
JSJoseph B Sempa
Joseph B Sempa
FBFelicity Burt
Felicity Burt
Aim: The aim of this study was to investigate the utility of serological tests for the diagnosis of COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT-PCR. ...

1 October 2011 in Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
IRInéz Rossouw
Inéz Rossouw
DGDominique Goedhals
Dominique Goedhals
JMJeanette van der Merwe
Jeanette van der Merwe
VSVictor Stallenberg
Victor Stallenberg
NGNelesh Govender
Nelesh Govender
Infection of the central nervous system (CNS) is a rare but devastating complication of invasive aspergillosis. We report a case of invasive aspergillosis with spinal involvement in a human immunodeficiency virus (HIV)-infected patient without neutropenia. A 42-year-old, antiretroviral-naïve, HIV-infected man presented with progressive weakness in the lower limbs and urinary and faecal incontinence for 2 weeks. The patient had been prescribed broad-spectrum antibiotics and prednisone. He had upper motor neuron signs and a sensory level at T1, with accompanying neck stiffness on flexion. Magnetic resonance imaging revealed diffuse abnormal signals of the vertebral bodies in the lower cervical and thoracic areas, with cord compression in the C2 and C3 region and signal distortions of the T2 and T3 vertebral bodies. Chest X-ray and computerized tomography demonstrated post-tuberculous apical cavities with suspected fungal colonization. Histopathology of an extradural spinal lesion at T1/T2 suggested invasive aspergillosis. The patient was started on fluconazole in response to the histopathological evidence of Aspergillus infection, but died within 3 weeks. Post-mortem analysis of the biopsy sample by PCR identified the infectious agent as Aspergillus fumigatus. Atypically, his CD4+ T-cell count was 239 cells mm−3 and he had no evidence of neutropenia. Invasive aspergillosis should be considered as part of the differential diagnosis among HIV-infected patients with non-specific, focal CNS symptoms, even among those without classical risk factors such as neutropenia, and aggressive antifungal therapy should be instituted as early as possible.

2 October 2019 in medRxiv
Verified
Preprint
Open access
PDF file
TMTongai G Maponga
Tongai G Maponga
AMAnna McNaughton
Anna McNaughton
MSMarije Van Schalkwyk
Marije Van Schalkwyk
SHSusan Hugo
Susan Hugo
CNChikezie Nwankwo
Chikezie Nwankwo
PMPhilippa C Matthews
Philippa C Matthews
Objective: Prompted by international targets for elimination of hepatitis B virus (HBV) infection, we performed a cross-sectional observational study of adults with chronic HBV (CHB) infection in South Africa, characterising individuals with HBV monoinfection vs. those coinfected with HBV/HIV, to evaluate the impact of therapy and to guide improvements in clinical care as guidelines for antiviral therapy change over time. Design: We prospectively recruited 115 adults with CHB, over a period of one year at a university hospital in Cape Town, South Africa. HIV coinfection was present in 39 (34%) subjects. We recorded cross-sectional demographic, clinical and laboratory data. Results: Adults with HBV monoinfection were comparable to those with HBV/HIV coinfection in terms of age, sex and body mass. HBeAg-positive status was more common among those with HIV coinfection (p=0.01). However, compared to HBV/HIV coinfection, HBV monoinfected patients were less likely to have had assessment with elastography (p<0.0001) and less likely to be on antiviral treatment (p2 (p=0.02). Three cases of hepatocellular carcinoma were documented, all in patients with HBV monoinfection. Conclusion: In this setting, individuals with HBV monoinfection are disadvantaged in terms of clinical assessment and appropriate antiviral therapy compared to those with HIV coinfection, associated with relatively worse liver health. Enhanced advocacy, education, resources and infrastructure are required to optimise interventions for CHB.

1 January 2024 in Southern African Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SMSindiswa S. Maphumulo
Sindiswa S. Maphumulo
DGDominique Goedhals
Dominique Goedhals
CRCornel van Rooyen
Cornel van Rooyen
SVSabeehah Vawda
Sabeehah Vawda
The seroepidemiology of hepatitis E virus (HEV) in South Africa is limited. We investigated anti-HEV IgM and IgG, in residual hepatitis A, B, and C negative serology specimens, at our public sector Free State (FS) laboratory. Of 299 specimens (01 May–31 October 2020), 182/299 (60.9%) had anti-HEV IgG and 1/299 (0.33%) had anti-HEV IgM. High HEV seroprevalence across different age groups suggests a different epidemiology in the FS, necessitating further research. Contribution: The need for HEV research in South Africa is highlighted. Clinicians should consider HEV in their differential diagnosis of patients with hepatitis.

1 January 2025 in Southern African Journal of HIV Medicine
Verified
Journal Article
Open access
PDF file
DMDevon Muir
Devon Muir
SVSabeehah Vawda
Sabeehah Vawda
PBPhillip Armand Bester
Phillip Armand Bester
CRCornel van Rooyen
Cornel van Rooyen
DGDominique Goedhals
Dominique Goedhals
Background: HIV and hepatitis B virus (HBV) coinfection impacts negatively on the prognosis for people living with HIV (PLHIV). HBV is relatively neglected compared to HIV in the South African setting, with limited coinfection seroprevalence data from the Free State. Objectives: This study aimed to determine the seroprevalence of current and previous HBV in PLHIV in the Free State, South Africa. Method: In this descriptive cross-sectional study, 1007 residual HIV viral load (VL) samples were selected and screened for markers of current HBV infection (hepatitis B surface antigen [HBsAg]) and previous exposure to HBV (total antibodies to hepatitis B core antigen [HBcTA]) between 01 February 2022 and 31 March 2022. Seroprevalence was assessed for municipal health districts, age, sex, and HIV VL categories. Results: HBsAg seroprevalence was 6.26% and HBcTA seroprevalence was 36.05%. HBsAg seroprevalence was significantly higher in men at 8.12% as compared to women at 4.38% (P = 0.014). HBcTA seropositivity was also higher in men than in women, at 42.97% for men and 29.08% for women (P < 0.0001). Peak HBsAg and HBcTA positivity was observed among the 40–59-year age group in both men and women. No significant difference was found in HBV seroprevalence and exposure between districts or HIV VL categories. Conclusion: These findings demonstrate that PLHIV in the Free State, South Africa, fall under the intermediate HBV prevalence category. HBV infection remains a public health concern and emphasis should be placed on identifying and addressing programmatic gaps regarding diagnosis and management.